Skip to content

MEDICAMIS

Active
Private limited companyfounded 2009active for 17 yearsRue d'Hornu 10, 7340 Colfontaine, BelgiumKBO/BCE: BE 0818.677.921
Summary

MEDICAMIS has been active since 2009 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €122,641 and a net result of €1,778. Equity is growing by about 9% per year across the filed financial years. Its solvency ranks better than 32% of 20,598 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

History

MEDICAMIS was incorporated on 16 September 2009.1 Total assets rose from €244,011 in 2018 to €307,938 in 2025 and headcount from 0.5 to 1 full-time equivalents.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
25-08
NBB filing Annual accounts filed
financial year 2025 · micro format · 25 days late
2025
31-12
Financial Back to profitnet €1,778
Net result €1,778 after one loss-making year.
29-08
NBB filing Annual accounts filed
financial year 2024 · micro format · 29 days late
2024
31-12
Financial Weakest financial yearnet -€33,360
Net result drops to -€33,360, the lowest in the series; recovery starts the following year.
07-10
NBB filing Annual accounts filed
financial year 2023 · micro format · 68 days late
2023
26-11
NBB filing Annual accounts filed
financial year 2022 · micro format · 118 days late
21-11
Gazette deed Appointment: Fabrice PUGGIONI (director)
Amendment of the articles · Capital conversion · Purpose change13 facts ▸
  • General meeting, 14-11-2023
  • Amendment of the articles (2 times)
  • Amendment of the articles, “Article 1er,alinéa 1er” (deed in French)
  • Capital conversion, “compte de capitaux propres statutairement indisponible” (deed in French)
  • Capital conversion, “compte de capitaux propres “apports non appelés”” (deed in French)
  • Other provision, “suppression du compte de capitaux propres statutairement indisponible, fonds disponibles pour distribution” (deed in French)
  • Other provision, “information sur distribution après mise à disposition du compte de capitaux propres, faire appel à un professionnel du chiffre” (deed in French)
  • Other provision, “rapport sur modification de l’objet, rapport de l’organe d’administration exposant justification” (deed in French)
  • Purpose change
  • Power of attorney, Anne TOUBEAUX
  • Director appointment, Fabrice PUGGIONI (director)
  • Registered office clause, “7340 COLFONTAINE, rue d’Hornu”, 10 (deed in French)
  • +1 further fact in this act
2022
31-12
Financial Highest result from 2018 to 2025net €60,759 ▲58.2%
Operating result €89,307, net result €60,759, both a record.
31-12
Financial Equity above €200,000equity €250,884 ▲32%
A profit in every financial year since 2018 builds equity to €250,884.
11-11
NBB filing Annual accounts filed
financial year 2021 · micro format · 103 days late
2021
22-11
NBB filing Annual accounts filed
financial year 2020 · micro format · 114 days late
2020
31-12
Financial Equity above €200,000equity €213,565 ▲36.9%
A profit in every financial year since 2018 builds equity to €213,565.
Show earlier events
30-11
NBB filing Annual accounts filed
financial year 2019 · micro format · 122 days late
2019
31-12
Financial Equity above €150,000equity €156,007 ▲51.1%
A profit in every financial year since 2018 builds equity to €156,007.
31-10
NBB filing Annual accounts filed
financial year 2018 · micro format · 92 days late
2018
30-09
NBB filing Annual accounts filed
financial year 2017 · micro format · 61 days late
2017
30-09
NBB filing Annual accounts filed
financial year 2016 · micro format · 61 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 16 annual accounts filed, the latest 10 are here; all 16 are under Financials.
1 of 2 deeds read
About the unread acts

Of the 2 Belgian Official Gazette deeds we know for this company, 1 has been read. The other one has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.